• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Contemporary Pediatrics week in review: Discussions of tralokinumab and antiretroviral therapy for HIV

News
Article

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Image credit: Contemporary Pediatrics

Image credit: Contemporary Pediatrics

Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, January 29 to Friday, February 2, 2024), and click on each link to read and watch anything you may have missed.

1.) A discussion of FDA-approved tralokinumab-ldrm for atopic dermatitis

In this Contemporary Pediatrics Q+A interview, Weily Soong, MD, breaks down FDA-approved tralokinumab-ldrm for patients aged 12 to 17 years with moderate-to-severe atopic dermatitis.

Click here to read the full discussion.

2.) Providing background on very early neonatal antiretroviral therapy to restrict HIV reservoirs

Deborah Persaud, MD, discusses the background and lead-up to her study examining very early ART in neonates born with HIV-1 and if this treatment could be a step towards ART-free treatment.

Click here to watch this video interview.

3.) Reaction to FDA approved dupilumab for eosinophilic esophagitis in children

Vivian Hernandez-Truillo, MD, FAAP, FAAAAI, FACAAI; and Theresa Bingemann, MD, provide reaction and commentary regarding recently FDA-approved dupilumab to treat EoE in pediatric patients aged 1 to 11 years.

Click here for full commentary and reaction.

4.) Quiz: Recommendations for influenza control in children from the American Academy of Pediatrics

The American Academy of Pediatrics (AAP) states that children consistently have the highest attack rates of influenza during seasonal influenza epidemics. Those with certain underlying medical conditions and those that are under 5 years of age can experience substantial morbidity, including severe or fatal complications, from influenza infection.

Click here to take the quiz.

5.) Withdrawn, somatic symptoms linked to doubled risk of suicidal thoughts in adolescents

A cohort analysis from Japan shows that more visible symptoms—though considered less clinical by experts—may be indicative of heightened suicidal behavior in teenagers.

Click here for the full article.

6.) Poll finds most parents say setting goals improves their parenting

Based on results from a recent C.S. Mott Poll on Children's Health, parents revealed their own goal-setting helped their children in working toward their respective goals.

Click here for the full poll report.

Be sure to read the January/February issue of Contemporary Pediatrics, here.

Related Videos
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
Steven Selbst, MD
© 2024 MJH Life Sciences

All rights reserved.